Molecular calix macrocyclic main compound based on resorcinol calix[4]arene derivatization, preparation method and application thereof
By introducing 2-hydroxymethylimidazolyl and water-soluble groups on the lezophenol cup[4] aromatic hydrocarbons to form the water-soluble molecular cup main bodies H1 and H2, the problem of limited recognition ability of the lezophenol cup in the water phase is solved. , realizes efficient identification of choline molecules and acetylcholine hydrolysis, and improves the application performance of the molecular cup.
Patent Information
- Application Number
- CN202210853796.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-07-12
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2042-07-12
AI Technical Summary
The existing lezophenol cup [4] aromatic derivatized molecular cup body has limited recognition ability in the aqueous phase and lacks functional guiding groups, resulting in limited application range, complex synthesis and difficult purification.
By introducing 2-hydroxymethylimidazolyl and water-soluble groups on the lyzophenol cup [4] aromatic framework, the water-soluble 2-hydroxymethylimidazolyl molecular cup bodies H1 and H2 are formed, increasing the cavity depth and recognition range , and the cavity diameter is reduced by forming a hydrogen bond array through the upper edge hydroxyl group, providing hydrogen bond recognition sites.
It realizes efficient identification of choline-like biological molecules in the aqueous phase, slows down the rate of object exchange, and promotes acetylcholine hydrolysis through a synergistic effect of weak alkaline environment, improving the recognition performance and application potential of molecular cups.
Smart Images

Figure CN115504988B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of macrocyclic host design and host-guest recognition in supramolecular chemistry, and relates to a molecular calix macrocyclic host based on resorcinol calix[4]arene derivatization, a preparation method thereof and an application thereof. Background Art
[0002] Calixarenes are a class of cyclic oligomers formed by the reaction of phenol monomers with aldehyde compounds, with methylene groups attached at the ortho position of the phenolic hydroxyl group. Like crown ethers and cyclodextrins, they have cavities that can accommodate guest molecules. Because their molecular structure resembles the Greek Holy Grail, they are called "calix[n]arene", where n represents the number of phenol monomers in the calixarene. The most widely studied calixarene is the tetrameric calix[4]arene. Compared with the previous two generations of main crown ethers and cyclodextrins, calixarene has the following advantages: 1) The size of the calixarene cavity is adjustable and easy to synthesize; 2) Calixarene is easy to modify, and different functional directing groups can be introduced at its upper and lower edges; 3) Calixarene has an electron-rich hydrophobic aromatic cavity that can recognize not only neutral molecules but also ionic compounds; 4) Calixarene has a variety of conformations that can be adjusted through host-guest interactions; 5) Calixarene has good chemical stability.
[0003] Resorcinol calix[4]arene is an important subclass of host molecules among calixarene. It is a cyclic oligomer formed by bridging resorcinol monomers with methylene groups at the ortho position of the phenolic hydroxyl group. Although resorcinol calix[4]arene is simple to synthesize and has stable properties, its application range is limited due to the lack of functional groups. Therefore, it is necessary to functionalize resorcinol calix[4]arene. In order to construct a resorcinol calix[4]arene-derived macrocyclic host molecule with a larger cavity, Cram et al. first reported a class of molecular cup hosts with quinoxaline aromatic walls in the early 1980s. This type of molecular cup host not only increases the depth of the calixarene cavity, but also expands the recognition range of the host molecule to the guest molecule. Computational simulation and NMR data show that this type of molecular cup has two conformations in solution: 4v Symmetrical "vase" conformation and C 2v Symmetrical "kite" conformation, and there is a dynamic balance between the two. When there is no suitable guest, in order to reduce the contact area with water, the "kite" conformation is self-complementary in shape and exists as a dimer through π-π stacking; when a suitable guest is present, the molecular cup changes from the "kite" conformation to a stable "vase" conformation. Based on the unique physical and chemical properties of the molecular cup body and good host-guest recognition performance, the molecular recognition application of this type of molecular cup in organic media has been widely studied.
[0004] However, in practical applications, water-phase molecular recognition has more important research significance. Most of the life processes of organisms are carried out in water environments, and the life processes are inseparable from water-phase molecular recognition. In recent years, supramolecular chemists have gradually solved the water solubility problem of this type of molecular cup body, used it to simulate the hydrophobic microenvironment of life receptors, and made certain progress in the field of biological molecule recognition in the water phase. However, the existing molecular cup bodies generally have problems such as lack of functional directing groups, complex synthesis and difficult purification. Therefore, improving the existing building blocks, synthesis methods and purification methods has become a research hotspot for supramolecular chemists. Summary of the invention
[0005] In order to solve the existing technical problems, the purpose of the present invention is to overcome the shortcomings of the existing technology and provide a molecular calix macrocyclic body based on resorcinol calix [4] arene derivatization, a preparation method and an application thereof. The molecular calix macrocyclic body based on resorcinol calix [4] arene derivatization of the present invention is a 2-hydroxymethyl imidazolyl molecular calix body H1 and H2 with good water solubility. This type of molecular calix body has an electron-rich hydrophobic cavity and can recognize choline biomolecules in the aqueous phase. The present invention uses resorcinol calix [4] arene as a skeleton, and successively deepens the aromatic wall, introduces the 2-hydroxymethyl imidazolyl group on the upper edge and the water-soluble group on the lower edge, thereby realizing the synthesis of new functionalized water-soluble 2-hydroxymethyl imidazolyl molecular calix bodies H1 and H2. The four hydroxyl groups on the upper edge of the body can form a ring-shaped stacked hydrogen bond array, narrowing the caliber of the cavity, thereby slowing down the exchange rate of the guest entering and exiting the cavity. At the same time, the four hydroxyl groups on the upper edge can provide hydrogen bond recognition sites for the guest molecule.
[0006] In order to achieve the above object, the present invention adopts the following technical scheme:
[0007] A water-soluble 2-hydroxymethylimidazolyl molecular calix host compound based on resorcinol calix [4] aromatic derivatives, which has an electron-rich aromatic cavity and can recognize choline biomolecules in an aqueous phase; the molecular calix H1 and H2 are shown in the structural formula; wherein the molecular calix H1 is a sodium carboxylate water-soluble group, and the molecular calix H2 is an N-methylimidazolium salt water-soluble group;
[0008]
[0009] Preferably, when the resorcinol calix[4]arene-derived supramolecular macrocyclic main body compound of the present invention has the structure of a molecular calix main body H1, the compound has a deep hydrophobic cavity, the main part of the cavity is a benzimidazole group, the upper edge is four hydroxyl groups, and the lower edge is a sodium carboxylate salt-soluble foot. The molecular calix main body H1 has two conformations in water; 4v Symmetrical "vase" conformation and C 2vSymmetrical "kite" conformation, and there is a dynamic balance between the two. Suitable guest molecules will induce the molecular cup to form a stable vase conformation and wrap the guest molecule in the cavity of the molecular cup.
[0010] Preferably, when the resorcinol calix[4]arene-derived supramolecular macrocyclic main body compound of the present invention has the structure of a molecular calix main body H2, the compound has a deep hydrophobic cavity, the main part of the cavity is a benzimidazole group, the upper edge is four primary hydroxyl groups, and the lower edge is an N-methylimidazolium salt-soluble foot. The molecular calix main body H2 has two conformations in water; 4v Symmetrical "vase" conformation and C 2v Symmetrical "kite" conformation, and there is a dynamic balance between the two. Suitable guest molecules will induce the molecular cup to form a stable vase conformation and be wrapped in the cavity of the molecular cup. The four hydroxyl groups on the upper edge of the main body of the present invention are brought closer to each other through hydrogen bonding, narrowing the caliber of the cavity, thereby slowing down the exchange rate of the guest molecules in and out of the cavity; at the same time, the four hydroxyl groups on the upper edge also provide hydrogen bond recognition sites for the guest molecules.
[0011] Preferably, when the resorcinol calix[4]arene-derived supramolecular macrocyclic host compound of the present invention has the structure of the molecular calix host H1, it can be used to recognize choline molecules. The anion foot and the cation foot of the molecular calix host have a certain influence on the recognition of choline molecules.
[0012] Preferably, when the resorcinol calix[4]arene-derived supramolecular macrocyclic host compound of the present invention has the structure of the molecular calix host H1, the molecular calix host H1 can promote the hydrolysis of acetylcholine through the synergistic effect of its own weak alkaline environment and the 2-hydroxymethylimidazolyl group on the upper edge. This function is similar to acetylcholinesterase.
[0013] A method for preparing a supramolecular macrocyclic main body compound derived from resorcinol calix[4]arene of the present invention uses resorcinol calix[4]arene as a skeleton, and successively deepens the aromatic wall, introduces 2-hydroxymethylimidazolyl groups on the upper edge and water-soluble groups on the lower edge, thereby achieving the synthesis of new functionalized water-soluble 2-hydroxymethylimidazolyl molecular calix main bodies H1 and H2.
[0014] Preferably, the method for preparing the supramolecular macrocyclic host H1 compound derived from resorcinol calix[4]arene of the present invention comprises the following synthetic steps:
[0015] a. Using ester-based octaamino hydrochloride molecular cup as raw material, add 10 times equivalent of glycolic acid thereto, and reflux in 4N hydrochloric acid for at least 3 days; after the reaction is completed, cool to room temperature, add ammonia water dropwise in an ice bath, adjust the pH to 8, and then filter to obtain a solid, wash the solid with deionized water at least 3 times, rinse with anhydrous ethanol at least once, collect the solid, and dry it under vacuum;
[0016] b. Add the product prepared in step a to a round-bottom flask, add ethanol solvent, and then add 5 equivalents of sodium hydroxide solid at room temperature. After stirring for at least 2 hours, filter directly and wash the solid with anhydrous ethanol at least 3 times. Collect the solid and dry it under vacuum for at least 3 days to obtain a water-soluble molecular cup H1.
[0017] Preferably, the method for preparing the supramolecular macrocyclic host H2 compound derived from resorcinol calix[4]arene of the present invention comprises the following synthesis steps:
[0018] ⅰ. Using octaamino hydrochloride molecular cup of chloroform as raw material, add 10 times equivalent of glycolic acid thereto, and reflux in 4N hydrochloric acid for at least 3 days; after the reaction is completed, cool to room temperature, add ammonia water dropwise in an ice bath, adjust the pH to 8, and then filter to obtain a solid, wash the solid with deionized water at least 3 times, rinse with anhydrous ethanol at least once, collect the solid, and dry it under vacuum;
[0019] ⅱ. Add the product prepared in step ⅰ to another round-bottom flask, add an appropriate amount of N-methylimidazole and stir at room temperature until the solid is completely dissolved, then connect a condenser and heat to not less than 90°C and stir vigorously, and react for at least 12 hours; after the reaction solution is cooled to room temperature, add acetone and a white solid precipitates, and obtain a crude product by centrifugation. Then, add acetone to the crude product and reflux overnight, finally cool to room temperature, filter, and wash the solid with acetone at least 3 times, collect the solid, and dry it under vacuum; the water-soluble molecular cup H2 is obtained.
[0020] Preferably, in step a, the molar ratio of the octaamino hydrochloride molecular cup of the ester base to the glycolic acid reactant is 1:25, and refluxed in 4N hydrochloric acid for more than 3 days. Post-treatment requires pH adjustment with ammonia water in an ice bath.
[0021] Preferably, in step b, the molar ratio of the product prepared in step a and the sodium hydroxide reactant is 1:5, wherein the concentration of the sodium hydroxide aqueous solution is not less than 1 mol / L, and the post-treatment requires washing away excess sodium hydroxide with a large amount of anhydrous ethanol.
[0022] Preferably, in step i, the molar ratio of the octaamino hydrochloride molecular cup of chlorine foot to the glycolic acid reactant is 1:25, and refluxed in 4N hydrochloric acid for more than 3 days. Post-treatment requires pH adjustment with ammonia water.
[0023] Preferably, in step ii, N-methylimidazole is not only a reactant but also a solvent for the reaction. The crude product obtained needs to be refluxed in acetone overnight to remove residual N-methylimidazole.
[0024] An application of a molecular calix host compound derived from resorcinol calix [4] arene of the present invention, wherein the 2-hydroxymethyl imidazolyl molecular calix hosts H1 and H2 have electron-rich hydrophobic cavities, and synergistically recognize choline biomolecules with trimethylammonium groups through cation···π interactions, electrostatic interactions, and other non-covalent interactions. At the same time, this type of host has potential applications in the fields of supramolecular catalysis, biomimetic recognition, and molecular reaction vessels.
[0025] Preferably, the choline molecules used to be recognized by the molecular cup bodies H1 and H2 include at least one of choline, acetylcholine, phosphorylcholine, L-carnitine, glycerophosphocholine and succinylcholine.
[0026] Compared with the prior art, the present invention has the following obvious outstanding substantial features and significant advantages:
[0027] 1. The synthetic route of the present invention is simple in process, the raw materials are readily available, the reaction conditions are mild, the yield is high, and the repeatability is good;
[0028] 2. The 2-hydroxymethylimidazolyl molecular cup bodies H1 and H2 of the present invention have novel structures. The four hydroxyl groups on the upper edge of the body can reduce the caliber of the cavity, slow down the exchange rate of the guest in and out of the cavity, and provide hydrogen bond recognition sites for the guest molecules. The molecular cup bodies H1 and H2 can recognize choline molecules, including choline, acetylcholine, phosphorylcholine, L-carnitine, glycerophosphorylcholine and succinylcholine, among which the bonding constant for choline molecules reaches 10 6 M -1 ;
[0029] 3. The molecular cup body H1 of the present invention can promote the hydrolysis of acetylcholine through the synergistic effect of its own weak alkaline environment and the 2-hydroxymethyl imidazole group on the upper edge; BRIEF DESCRIPTION OF THE DRAWINGS
[0030] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0031] Figure 1 This is the H NMR spectrum of the molecular cup H1 in Example 1 of the present invention (600 MHz, DMSO-d6:D2O=1:9, v / vmL, 298K).
[0032] Figure 2 This is the NMR carbon spectrum (151 MHz, DMSO-d6, 298 K) of the molecular cup H1 in Example 1 of the present invention.
[0033] Figure 3 This is a high-resolution mass spectrum of the molecular cup H1 in Example 1 of the present invention.
[0034] Figure 4 This is the H NMR spectrum of the molecular cup H2 in Example 1 of the present invention (600 MHz, DMSO-d6:D2O=1:9, v / vmL, 298K).
[0035] Figure 5 This is the NMR carbon spectrum (151 MHz, DMSO-d6, 298 K) of the molecular cup H2 in Example 1 of the present invention.
[0036] Figure 6 This is a high-resolution mass spectrum of the molecular cup H2 in Example 1 of the present invention.
[0037] Figure 7 This is a diagram showing the rapid transformation of two different conformations of the molecular cup H1 in Example 1 of the present invention in the aqueous phase: the rapid transformation of the dimer and the vase conformation.
[0038] Figure 8 The NMR proton spectra of two conformations of the molecular cup H1 in Example 1 of the present invention in heavy water. The illustration a) is the kite-shaped conformation of dimerization in the absence of a guest, and the asterisks indicate a small amount of Complex; Illustration b) is the vase-shaped conformation with DMSO as the guest molecule, that is Complex (C 4v Symmetrical vase conformation).
[0039] Fig. 9 This is the host-guest complex NMR spectrum (600MHz, D2O, 298K) of the molecular cup H1 (1mmol / L, 500μL) in Example 1 of the present invention for the recognition of choline molecules (50mmol / L, 10μL). Inset a) is glycerophosphorylcholine; inset b) is phosphorylcholine; inset c) is L-carnitine; inset d) is acetylcholine; inset e) is choline.
[0040] Fig.10 This is the hydrogen spectrum (600MHz, D2O, 298K) of the nuclear magnetic titration experiment of the molecular cup H1 (concentration of 1mM) and the choline molecule in Example 1 of the present invention. Among them, the illustration a) is 0.2 equivalent of choline molecule; the illustration b) is 0.4 equivalent of choline molecule; the illustration c) is 0.6 equivalent of choline molecule; the illustration d) is 0.8 equivalent of choline molecule and the illustration e) is 1.0 equivalent of choline molecule.
[0041] Fig.11 The hydrogen spectra monitored by nuclear magnetic resonance (NMR) of the molecular calix H1 in Example 1 of the present invention promoting the hydrolysis of acetylcholine molecules. In particular, the illustration a) is a schematic diagram of the hydrolysis of acetylcholine; the illustration b) is the hydrogen NMR monitoring spectrum (600 MHz, D2O, 298 K) of the hydrolysis of acetylcholine (concentration 1 mM) promoted by the water-soluble molecular calix H1 (concentration 1 mM) at different ultrasonic times.
[0042] Fig.12 This is the host-guest complex NMR spectrum (600MHz, D2O, 298K) of the molecular cup H2 (1mmol / L, 500μL) recognizing the choline molecule (50mmol / L, 10μL) in Example 1 of the present invention. Inset a) L-carnitine; inset b) acetylcholine; inset c) choline.
[0043] Fig.13 This is a graph showing the results of the second isothermal titration calorimetry test of the molecular cup H1 (concentration of 0.2 mM) and choline (concentration of 2 mM) in Example 1 of the present invention. The upper part of the graph is the original titration curve, and the lower part is the reaction heat curve obtained by integrating the titration curve.
[0044] Fig.14 Schematic diagram of the structure of the water-soluble 2-hydroxymethylimidazolyl molecular cup bodies H1 and H2 of the present invention. DETAILED DESCRIPTION
[0045] The present invention will be further described in detail below in conjunction with specific embodiments. It should be noted that the specific embodiments are intended to explain the present invention rather than to limit it. The preferred embodiments of the present invention are described in detail as follows:
[0046] Embodiment 1:
[0047] In this embodiment, the synthesis of new functionalized water-soluble 2-hydroxymethylimidazolyl molecular cup bodies H1 and H2 is achieved by using resorcinol calix [4]arene as the skeleton, deepening the aromatic wall, introducing 2-hydroxymethylimidazolyl on the upper edge, and sodium carboxylate and N-methylimidazolium salt-soluble groups on the lower edge. The four hydroxyl groups on the upper edge of the body form a ring-shaped stacked hydrogen bond and reduce the caliber of the cavity, thereby slowing down the exchange rate of the guest in and out of the cavity. Moreover, the four hydroxyl groups on the upper edge of this type of molecular cup body can provide hydrogen bond recognition sites for guest molecules. The structural formulas of molecular cups H1 and H2 are as follows:
[0048]
[0049] A method for preparing a supramolecular macrocyclic main body compound derived from resorcinol calix [4]arene in this embodiment, using ester-based octaamino hydrochloride molecular calix S1 as a starting reaction raw material, preparing a water-soluble 2-hydroxymethylimidazolyl molecular calix main body H1, introducing carboxylic acid sodium salt at the lower edge to achieve water solubility as a whole, and introducing 2-hydroxymethylimidazolyl at the upper edge by condensation of glycolic acid and o-phenylenediamine, so that the middle part becomes a benzimidazole group, and the synthesis steps are as follows:
[0050]
[0051] The preparation method of the resorcinol calix[4]arene-derived supramolecular macrocyclic host compound H1 in this embodiment comprises the following synthesis steps:
[0052] a. The ester-based octaamino hydrochloride molecular calix compound S1 (300 mg, 0.23 mmol, 1 eq) and glycolic acid (436 mg, 5.75 mmol, 25 eq) were placed in a 50 mL flask, and 25 mL of 4 mol / L hydrochloric acid was added. A condenser was installed and heated to 100 ° C under nitrogen protection and refluxed for 72 hours; after the reaction was completed, it was cooled to room temperature, and ammonia water was added dropwise in an ice bath to adjust the pH to 8; filtered, the filter cake was washed 3 times with 15 mL of deionized water, and quickly rinsed once with 10 mL of anhydrous ethanol, the solid was collected and dried under vacuum to obtain compound S2, which was a brown solid of 225 mg with a yield of 85%;
[0053] b. The product S2 (200 mg, 0.15 mmol, 1 eq) prepared in step a was placed in a 25 mL round-bottom flask, followed by the addition of 10 mL of anhydrous ethanol and sodium hydroxide (32 mg, 0.78 mmol, 5 eq), and stirred at room temperature for 2 hours. After the reaction stopped, it was directly filtered and washed 3 times with 10 mL of anhydrous ethanol. The solid was collected and dried under vacuum for 3 days to obtain a water-soluble molecular cup H1 as a khaki solid of 184 mg with a yield of 86%.
[0054] In this example, the intermediate product S2 was characterized by NMR and mass spectrometry. 1 H NMR (400MHz, DMSO-d6:D2O=9:1,v / v mL,δppm)δ8.13(s,8H),7.96(s,4H),7.70(s,4H),5.56(t,J=8.2Hz,4H),4.68(s,8H),2.54(m,8H),2.20(t,J=7.1Hz,8H). 13 C NMR (151MHz, DMSO-d6, δppm): 174.5, 156.6, 156.0, 151.0, 135.4, 129.1, 125.3, 117.5, 109.8, 33.3, 32.5, 27.3.ESI-HRMS: Calcd.for chemical formula C 72 H 55 N8O 20 :1351.3611,found 1351.3525.[MH] - .
[0055] In this embodiment, see Figure 1-Figure 3 The molecular cup H1 was characterized by NMR and mass spectrometry. 1H NMR(600MHz,D2O:DMSO-d6=9:1,v / v mL,δppm)δ7.91(s,8H),7.82(s,4H),7.68(s,4H),5.69(t,J=8.3Hz,4H),4.71(s,8H),2.66(d,J=7.8Hz,8H),2.24(t,J=7.3Hz,8H). 13 C NMR (151MHz, D2O:DMSO-d6=9:1, v / v mL, δppm)181.8,157.3,155.7,148.4,135.7,135.5,124.4,116.9,109.6,35.8,33.4,28.3.ESI-HRMS:Calcd.for chemical formula C 72 H 55 N8O 20 :1351.3611,found1351.3525.[M-4Na+3H] - .
[0056] A method for preparing a supramolecular macrocyclic host compound derived from resorcinol calix[4]arene in this embodiment, using octaamino hydrochloride molecular calix S3 of chloroform as a starting reaction material, preparing a water-soluble 2-hydroxymethylimidazolyl molecular calix host H2, introducing N-methylimidazolium salt at the lower edge to achieve water solubility as a whole, and introducing 2-hydroxymethylimidazolyl at the upper edge by condensation of glycolic acid and o-phenylenediamine, so that the middle part becomes a benzimidazole group; the synthesis steps are as follows:
[0057]
[0058] The preparation method of the resorcinol calix[4]arene-derived supramolecular macrocyclic host compound H2 in this embodiment comprises the following synthesis steps:
[0059] ⅰ. The octaamino hydrochloride molecular cup S3 (300 mg, 0.25 mmol, 1 eq) and glycolic acid (475 mg, 6.19 mmol, 20 eq) of the chloroform were placed in a 50 mL flask, and 25 mL of 4 mol / L hydrochloric acid was added. A condenser was installed and the mixture was heated to 100 ° C and refluxed for 72 hours under nitrogen protection. After the reaction was completed, the mixture was cooled to room temperature, and ammonia water was added dropwise in an ice bath to adjust the pH to 8. The mixture was filtered, and the filter cake was washed 3 times with 30 mL of deionized water and quickly rinsed once with 10 mL of anhydrous ethanol. The solid was collected and dried under vacuum to obtain compound S4, which was a brown solid of 220 mg with a yield of 65%.
[0060] ii. The product S4 (200 mg, 0.15 mmol) prepared in step i was placed in a 25 mL round-bottom flask, 15 mL of N-methylimidazole was added and stirred at room temperature until the solid was completely dissolved, then a condenser was connected and heated to 90 ° C and stirred vigorously, and the reaction was carried out for 12 hours. After the reaction solution was cooled to room temperature, the reaction solution was added dropwise to 100 mL of acetone, and an off-white solid was precipitated. A solid crude product was obtained by centrifugation. The obtained crude product was then added to 30 mL of acetone and refluxed overnight, and finally cooled to room temperature and filtered, and the filter cake was washed 3 times with 20 mL of acetone, and the solid was collected and dried under vacuum to obtain a water-soluble molecular cup H2, which was a light yellow solid of 160 mg, with a yield of 67%.
[0061] In this example, the intermediate product S4 was characterized by NMR and mass spectrometry. 1 H NMR (600MHz, DMSO-d6:D2O=9:1,v / v mL, δppm) δ7.90 (s, 7H), 7.78 (s, 4H), 7.65 (s, 4H), 5.61 (t, J = 7.0Hz, 4H), 4. 50(s,8H),3.70(t,J=6.2Hz,8H),2.45(s,8H),1.71(dt,J=11.7,5.7Hz,8H). 13 C NMR (151MHz, DMSO-d6, δppm): 156.7, 156.0, 148.6, 135.4, 124.9, 117.4, 45.5, 33.1, 31.3, 29.3.ESI-HRMS: Calcd. for chemical formula C 72 H 59 CI4N8O 20 :1367.3085,found1367.3001[MH] - .
[0062] In this embodiment, see Figure 4-Figure 6 The molecular cup H2 was characterized by NMR and mass spectrometry. 1 H NMR(600MHz,D2O:DMSO-d6=5:1,v / v mL,δppm)δ8.89(s,3H),7.93(s,8H),7.84(s,5H),7.78(s,4H),7.53(d,J=26.4Hz,9H),5.61(t ,J=8.5Hz,4H),4.39(t,J=6.7Hz,8H),3.92(s,13H),2.56(m,8H),1.98(dt,J=14.2,6.9Hz,8H). 13C NMR (151MHz, DMSO-d6, δppm): δ156.7,155.9,148.3,136.9,135.4,125.8,123.9,122.8,117.3,49.6,36.3,33.9,31.1,28.7.ESI-HRMS:Calcd.for chemical formula C 88 H 84 CI4N 16 O 20 :1696.5203,found:813.2913[(M-2CI) / 2] + .
[0063] Host-guest NMR data analysis:
[0064] Molecular cup H1 (14.40 mg, 10.00 μmol) was added to a 25 mL sample bottle, 10 mL of heavy water was added, and it was completely dissolved by ultrasonication to obtain a clear and transparent light yellow solution (1 mmol / L).
[0065] Take 500 μL of the above molecular cup H1 solution and add it to the NMR tube, then take 10 μL, 50 mmol / L heavy water solution of choline molecules and add it to the NMR tube, mix the solutions and measure the 298K NMR hydrogen spectrum on a Bruker AVANCEⅢHD 600M machine, the spectrum width of the scan is set to 25, the center is 5, and the number of scans is 64.
[0066] Analysis of two conformations of molecular cup H1 by H NMR spectrum: There are two conformations of molecular cup H1 in water, and these two conformations can transform into each other. Figure 7 When there is no suitable guest, the molecular cup H1 exists in a dimer kite-shaped conformation. At this time, the characteristic peak of the methine in the molecule (H d ) chemical shift value is about 4.0ppm. When a suitable guest enters the cavity of the host, the host molecule takes on a "vase" conformation. At this time, H d The chemical shift of is shifted downfield to 5.7 ppm. Figure 8 .
[0067] H-NMR spectrum analysis of the host-guest complex of molecular cup H1 and choline molecules: Molecular cup H1 has an electron-rich hydrophobic cavity, so it has a good recognition ability for choline biological molecules containing trimethylammonium groups. From the hydrogen spectrum of the host-guest complex of choline molecules and molecular cup H1, it can be found that the trimethylammonium group of the choline molecule is bound to the bottom of the hydrophobic cavity through the synergistic effects of cationic···π effects, electrostatic effects and other non-covalent bonds, thus being strongly shielded. The chemical shift change value (Δδ) reaches -5ppm, and the tail of the choline molecule points to the open end of the cavity. Fig. 9 shown.
[0068] Analysis of H1 NMR titration spectrum of molecular cup H1 and choline molecules: In the solution of molecular cup H1 (500μL, 1mM inD2O), as choline molecules are gradually added, the dimer of the main body is separated, and the choline molecules enter the cavity of H1. Due to the shielding effect of its wall, a new signal peak appears in the high field of the H1 NMR spectrum. Fig.10 As shown. Among them, the trimethylammonium group of the choline molecule is bound to the bottom of the hydrophobic cavity through cation···π and CH···π interactions or electrostatic interactions, thereby being strongly shielded, and the chemical shift change value (Δδ) reaches -4.8ppm, while its hydrophilic group hydroxyl group points to the open end of the cavity. When 1 equivalent of choline molecules is added, a weak free choline molecule signal peak appears in the nuclear magnetic hydrogen spectrum. The nuclear magnetic integrated area ratio of the host and guest molecules confirms that the choline molecule and the H1 complex have a 1:1 bonding mode. As shown Fig.10 shown.
[0069] Analysis of H1 NMR spectrum of acetylcholine molecule hydrolysis promoted by molecular cup H1: Add the prepared acetylcholine solution (10μL, 50mM in D2O) and the main H1 solution (500μL, 1mM in D2O) into the NMR tube with an equivalent ratio of 1:1. After shaking, the NMR tube is quickly placed in the ultrasonic pool for ultrasound and the timing is started. At first, the hydrolysis of acetylcholine is fast and the monitoring time is relatively intensive. The H1 NMR spectrum is detected every 10 minutes. 1 The H NMR spectrum shows that acetylcholine begins to hydrolyze into choline, and a new set of peaks appears in the high field region at -1.58ppm and -1.07ppm. As the reaction proceeds, the peak of acetylcholine gradually weakens, and the peak of choline gradually strengthens. After 60 minutes of reaction, the reaction slows down, and the detection time interval is controlled to once every 30 minutes. Finally, acetylcholine is completely hydrolyzed within 250 minutes. Fig.11 shown.
[0070] Analysis of the host-guest complex of molecular calix H2 and choline molecules by H NMR spectrum: Molecular calix H2 has an electron-rich hydrophobic cavity, so it has a good recognition ability for choline biological molecules containing trimethylammonium groups. From the H NMR spectrum of the host-guest complex of choline, acetylcholine and L-carnitine with molecular calix H2, it can be found that the trimethylammonium group of this type of molecule is bound to the bottom of the hydrophobic cavity, thus being strongly shielded, and the chemical shift change value (Δδ) reaches -5ppm, and its tail points to the open end of the cavity. Fig.12 shown.
[0071] Isothermal Titration Calorimetry Data Analysis:
[0072] Isothermal titration calorimetry data were collected by a MicroCal VP-ITC machine. 1.42 mL of H1 deionized water solution (concentration of 0.2 mM) was placed in the sample cell, and then a 2 mM choline solution (292 μL) was placed in the syringe. Each titration experiment was injected 26 times, 2 μL each time, and 360 seconds were left between each injection. The dilution heat data generated by the blank solvent dripping into the sample cell was deducted from each set of data. The measured data can be fitted by the "one set of binding sites" model simulated by a computer. The experiment was repeated three times, and the binding constant measurement value was averaged for three times. The isothermal titration calorimetry experiment measured the bonding constant of the molecular cup H1 to the choline molecule to be (1.75±0.3)×10 6 M -1 , which indicates that choline has a strong interaction with the host H1. In addition, ΔH°<0; TΔS°>0, indicating that the host-guest complexation process is driven by both enthalpy and entropy. Fig.13 shown.
[0073] In summary, the present invention synthesized 2-hydroxymethylimidazolyl molecular calix H1 and H2 with good water solubility. Fig.14 As shown. On the resorcinol cup [4] aromatic hydrocarbon skeleton, the synthesis of new functionalized water-soluble 2-hydroxymethylimidazolyl molecular cup bodies H1 and H2 was achieved by deepening the aromatic wall, introducing 2-hydroxymethylimidazolyl groups on the upper edge, and sodium carboxylate and N-methylimidazolium salt-soluble groups on the lower edge. The four hydroxyl groups on the upper edge of the two molecular cup bodies can form ring-stacked hydrogen bonds and reduce the caliber of the cavity, thereby slowing down the exchange rate of the guest in and out of the cavity. At the same time, the four hydroxyl groups on the upper edge of the molecular cup can provide hydrogen bond recognition sites for the guest molecules. Based on the structural characteristics of the molecular cups H1 and H2, choline molecules, including choline, acetylcholine, phosphorylcholine, L-carnitine, glycerophosphocholine and succinylcholine, can be recognized, among which the bonding constant for choline molecules reaches 10 6 M -1The molecular cup H1 can promote the hydrolysis of acetylcholine through the synergistic effect of its own weak alkaline environment and the 2-hydroxymethyl imidazole group on the upper edge. These experimental results show that the molecular cups H1 and H2 have excellent host-guest recognition performance, and the inventors are conducting further research on this.
[0074] Finally, it should be noted that the above is only a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, researchers in this field can still modify the research schemes recorded in the aforementioned embodiments, or make equivalent replacements for parts of them. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention. Although the above describes the specific implementation methods of the present invention, it is not a limitation on the protection scope of the present invention. Researchers in the relevant field should understand that on the basis of the technical solution of the present invention, various modifications or deformations that researchers in this field can make without creative work are still within the protection scope of the present invention.
Claims
1. A water-soluble molecular calix macrocyclic main body compound based on resorcinol calix[4]arene derivatization, characterized in that: It is a water-soluble 2-hydroxymethylimidazolyl molecular cup body, and its structural formula is shown in Figures H1 and H2 below: The molecular cup H1 is a sodium carboxylate water-soluble group, and the molecular cup H2 is an N-methylimidazolium salt water-soluble group.
2. A method for preparing the water-soluble molecular calix macrocyclic main compound H1 based on resorcinol calix[4]arene derivatization according to claim 1, characterized in that: The steps include: a. Using ester-based octaamino hydrochloride molecular cup as raw material, add 10 times the equivalent of glycolic acid thereto, and reflux in 4N hydrochloric acid for at least 3 days; after the reaction is completed, cool to room temperature, add ammonia water dropwise in an ice bath, adjust the pH to 8, and then filter to obtain a solid, wash the solid with deionized water at least 3 times, rinse with anhydrous ethanol at least once, collect the solid, and dry it under vacuum; the structural formula of the ester-based octaamino hydrochloride molecular cup is as follows: b. Add the product prepared in step a to a round-bottom flask, add ethanol solvent, and then add 5 equivalents of sodium hydroxide solid at room temperature. After stirring for at least 2 hours, filter directly and wash the solid with anhydrous ethanol at least 3 times. Collect the solid and dry it under vacuum for at least 3 days to obtain a water-soluble molecular cup H1.
3. A method for preparing the water-soluble molecular calix macrocyclic host compound H2 based on resorcinol calix[4]arene derivatization according to claim 1, characterized in that: The steps include: ⅰ. Using octaamino hydrochloride molecular cup of chlorine foot as raw material, add 10 times equivalent of glycolic acid thereto, and reflux in 4N hydrochloric acid for at least 3 days; after the reaction is completed, cool to room temperature, add ammonia water dropwise in an ice bath, adjust the pH to 8, and then filter to obtain a solid, wash the solid with deionized water at least 3 times, rinse with anhydrous ethanol at least once, collect the solid, and dry it under vacuum; the structural formula of octaamino hydrochloride molecular cup of chlorine foot is as follows: ⅱ. Add the product prepared in step ⅰ to another round-bottom flask, add an appropriate amount of N-methylimidazole and stir at room temperature until the solid is completely dissolved, then connect a condenser and heat to not less than 90°C and stir vigorously, and react for at least 12 hours; after the reaction solution is cooled to room temperature, add acetone and a white solid precipitates, and obtain a crude product by centrifugation. Then, add acetone to the crude product and reflux overnight, finally cool to room temperature, filter, and wash the solid with acetone at least 3 times, collect the solid, and dry it under vacuum; the water-soluble molecular cup H2 is obtained.
4. An application of the water-soluble molecular calix macrocyclic main body compound based on resorcinol calix[4]arene derivatization according to claim 1, characterized in that: The water-soluble 2-hydroxymethylimidazolyl molecular cup bodies H1 and H2 synergistically recognize choline biomolecules with trimethylammonium groups through cation-π interactions, electrostatic interactions, and other non-covalent bonding interactions.
5. The use of the water-soluble molecular calix macrocyclic host compound based on resorcinol calix[4]arene derivatization according to claim 4, characterized in that: The molecular cup body H1 promotes the hydrolysis of acetylcholine through the synergistic effect of its own weakly alkaline environment and the 2-hydroxymethylimidazolyl group on the upper edge.
6. The use of the water-soluble molecular calix macrocyclic host compound based on resorcinol calix[4]arene derivatization according to claim 4, characterized in that: The choline molecules recognized by the molecular cup bodies H1 and H2 are selected from at least one of choline, acetylcholine, phosphorylcholine, L-carnitine, glycerophosphorylcholine and succinylcholine.
